Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Straumann Holding AGXSWX:STMN +0.34%100 EV-to-OCF is 31.55 as of Jul. 16, 2026, which is 26% below its 10-year median of 42.64. GuruFocus rates XSWX:STMN with a GF Score™ of 100/100 and a GF Value™ of CHF137.52 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 85.5% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Straumann Holding AG's Enterprise Value is CHF15,903 Mil.
Straumann Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF504 Mil. Therefore, Straumann Holding AG's EV-to-OCF for today is 31.55.
The historical rank and industry rank for Straumann Holding AG's EV-to-OCF or its related term are showing as below:
XSWX:STMN'
s EV-to-OCF Range Over the Past 10 Years
Min: 23.88 Med: 42.64 Max: 86.94
Current: 33.15
During the past 13 years, the highest EV-to-OCF of Straumann Holding AG was 86.94. The lowest was 23.88. And the median was 42.64.
XSWX:STMN's EV-to-OCF is ranked worse than 85.5% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 8.05
vs XSWX:STMN: 33.15
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Straumann Holding AG (XSWX:STMN) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Straumann Holding AG's PE Ratio (TTM) for today is calculated as:
Straumann Holding AG's share price for today is CHF100.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Straumann Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF2.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Straumann Holding AG EV-to-OCF Related Terms
Straumann Holding AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: EV-to-OCF Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's EV-to-OCF falls into.
Straumann Holding AG's current Enterprise Value is CHF15,903 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Straumann Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF504 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a EV-to-OCF of 31.55 as of Jul. 16, 2026. This is 26% below median its historical median of 42.64. Over the past decade, Straumann Holding AG's EV-to-OCF has ranged from 23.88 to 86.94. According to the industry distribution chart, Straumann Holding AG ranks #731 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 85.5%.
Is Straumann Holding AG's EV-to-OCF too high?
Straumann Holding AG's current EV-to-OCF of 31.55 is 26% below median its 10-year median of 42.64. Over the past 10 years, this metric has ranged from a low of 23.88 to a high of 86.94. The Medical Devices & Instruments industry median EV-to-OCF is 8.05. Straumann Holding AG's value of 31.55 is 291.9% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #731 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Straumann Holding AG has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #731 out of 855 companies for EV-to-OCF. This places Straumann Holding AG in the lower half of its industry. The industry median EV-to-OCF is 8.05. Straumann Holding AG's value of 31.55 is 291.9% above this benchmark. Historically, Straumann Holding AG's own EV-to-OCF has ranged from 23.88 to 86.94 over the past decade. While the company's 10-year median is 42.64 vs. the industry median of 8.05, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 8.05, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current EV-to-OCF of 31.55 is 291.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current EV-to-OCF is 31.55, which is 26% below median its own 10-year median of 42.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.52, compared to a current price of CHF100.15 — trading 27.2% below its estimated fair value. The current EV-to-OCF is 31.55, which is 26% below median its 10-year median of 42.64 and 291.9% above the Medical Devices & Instruments industry median of 8.05. Straumann Holding AG's overall GF Score™ is 100/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current EV-to-OCF is 31.55 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF100.15 is trading 27.2% below its estimated GF Value™ of CHF137.52.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
EV-to-OCF: 31.55 (26% below median its 10-year median of 42.64)
GF Value™: CHF137.52 vs. price of CHF100.15 (27.2% below fair value)
Industry Position: 291.9% above the Medical Devices & Instruments median (#731 of 855)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
100GF Score
Get the complete analysis for XSWX:STMN
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
